These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25618016)

  • 61. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
    Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
    PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potent activity against multidrug-resistant Mycobacterium tuberculosis of α-mangostin analogs.
    Sudta P; Jiarawapi P; Suksamrarn A; Hongmanee P; Suksamrarn S
    Chem Pharm Bull (Tokyo); 2013; 61(2):194-203. PubMed ID: 23150066
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Design, green synthesis, antioxidant activity screening, and evaluation of protective effect on cerebral ischemia reperfusion injury of novel monoenone monocarbonyl curcumin analogs.
    He W; Wang J; Jin Q; Zhang J; Liu Y; Jin Z; Wang H; Hu L; Zhu L; Shen M; Huang L; Huang S; Li W; Zhuge Q; Wu J
    Bioorg Chem; 2021 Sep; 114():105080. PubMed ID: 34225164
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis.
    Hegeto LA; Caleffi-Ferracioli KR; Nakamura-Vasconcelos SS; Almeida AL; Baldin VP; Nakamura CV; Siqueira VLD; Scodro RBL; Cardoso RF
    Tuberculosis (Edinb); 2018 Jul; 111():35-40. PubMed ID: 30029912
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preliminary evaluation of anti-tuberculosis potential of siderophores against drug-resistant Mycobacterium tuberculosis by mycobacteria growth indicator tube-drug sensitivity test.
    Gokarn K; Pal RB
    BMC Complement Altern Med; 2017 Mar; 17(1):161. PubMed ID: 28327117
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhance the Antimycobacterial Activity of Streptomycin with Ebselen as an Antibiotic Adjuvant Through Disrupting Redox Homeostasis.
    Dong C; Wang Y; Cai Y; Wu Y; Chen W; Wang L; Liu X; Zou L; Wang J
    Drug Des Devel Ther; 2024; 18():3811-3824. PubMed ID: 39219694
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monocarbonyl Analogs of Curcumin Based on the Pseudopelletierine Scaffold: Synthesis and Anti-Inflammatory Activity.
    Pawelski D; Walewska A; Ksiezak S; Sredzinski D; Radziwon P; Moniuszko M; Gandusekar R; Eljaszewicz A; Lazny R; Brzezinski K; Plonska-Brzezinska ME
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768818
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
    Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
    Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.
    Narender M; Jaswanth S B; Umasankar K; Malathi J; Raghuram Reddy A; Umadevi KR; Dusthackeer AVN; Venkat Rao K; Raghuram R A
    Bioorg Med Chem Lett; 2016 Feb; 26(3):836-840. PubMed ID: 26755393
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro bioevaluation and docking study of dihydrosphingosine and ethambutol analogues against sensitive and multi-drug resistant Mycobacterium tuberculosis.
    Linhares LA; Dos Santos Peixoto A; Correia de Sousa LA; Lucena Laet JP; da Silva Santos AC; Alves Pereira VR; Carneiro Neves MM; Ferreira LFGR; Hernandes MZ; de la Vega J; Pereira-Neves A; San Feliciano A; Olmo ED; Schindler HC; Montenegro LML
    Eur J Med Chem; 2023 Oct; 258():115579. PubMed ID: 37399709
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recent updates on drug resistance in Mycobacterium tuberculosis.
    Singh R; Dwivedi SP; Gaharwar US; Meena R; Rajamani P; Prasad T
    J Appl Microbiol; 2020 Jun; 128(6):1547-1567. PubMed ID: 31595643
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment.
    Hu Y; Zhao Q; Werngren J; Hoffner S; Diwan VK; Xu B
    BMC Infect Dis; 2016 Jan; 16():4. PubMed ID: 26739444
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance.
    Revalde JL; Li Y; Hawkins BC; Rosengren RJ; Paxton JW
    Biochem Pharmacol; 2015 Feb; 93(3):305-17. PubMed ID: 25543853
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Benzothiazole analogs as potential anti-TB agents: computational input and molecular dynamics.
    Venugopala KN; Khedr MA; Pillay M; Nayak SK; Chandrashekharappa S; Aldhubiab BE; Harsha S; Attimard M; Odhav B
    J Biomol Struct Dyn; 2019 Apr; 37(7):1830-1842. PubMed ID: 29697293
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.
    Wang XH; Ma AG; Han XX; Gu XM; Fu LP; Li PG; Li FY; Wang QZ; Liang H; Katar A; Wang LJ
    Med Sci Monit; 2015 May; 21():1313-8. PubMed ID: 25950148
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
    Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
    Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Using a Heat Diffusion Model to Detect Potential Drug Resistance Genes of
    Cui ZJ; Zhang WT; Zhu Q; Zhang QY; Zhang HY
    Protein Pept Lett; 2020; 27(8):711-717. PubMed ID: 32167422
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High prevalence of primary drug resistance in children with intrathoracic tuberculosis in India.
    Prajapati S; Upadhyay K; Mukherjee A; Kabra SK; Lodha R; Singh V; Grewal HM; Singh S;
    Paediatr Int Child Health; 2016 Aug; 36(3):214-8. PubMed ID: 26052730
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.